chr6-43770057-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003376.6(VEGFA):​c.-650A>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.557 in 291,570 control chromosomes in the GnomAD database, including 46,593 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.58 ( 26554 hom., cov: 32)
Exomes 𝑓: 0.53 ( 20039 hom. )

Consequence

VEGFA
NM_003376.6 upstream_gene

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.171

Publications

57 publications found
Variant links:
Genes affected
VEGFA (HGNC:12680): (vascular endothelial growth factor A) This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-43770057-A-G is Benign according to our data. Variant chr6-43770057-A-G is described in ClinVar as Benign. ClinVar VariationId is 1245515.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003376.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
NM_003376.6
MANE Select
c.-650A>G
upstream_gene
N/ANP_003367.4
VEGFA
NM_001025366.3
c.-650A>G
upstream_gene
N/ANP_001020537.2
VEGFA
NM_001025367.3
c.-650A>G
upstream_gene
N/ANP_001020538.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VEGFA
ENST00000672860.3
MANE Select
c.-650A>G
upstream_gene
N/AENSP00000500082.3
VEGFA
ENST00000425836.9
TSL:1
c.-650A>G
upstream_gene
N/AENSP00000388465.4
VEGFA
ENST00000372067.8
TSL:1
c.-650A>G
upstream_gene
N/AENSP00000361137.4

Frequencies

GnomAD3 genomes
AF:
0.583
AC:
88483
AN:
151758
Hom.:
26525
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.735
Gnomad AMI
AF:
0.278
Gnomad AMR
AF:
0.607
Gnomad ASJ
AF:
0.548
Gnomad EAS
AF:
0.724
Gnomad SAS
AF:
0.554
Gnomad FIN
AF:
0.448
Gnomad MID
AF:
0.548
Gnomad NFE
AF:
0.503
Gnomad OTH
AF:
0.613
GnomAD4 exome
AF:
0.528
AC:
73753
AN:
139700
Hom.:
20039
AF XY:
0.525
AC XY:
36048
AN XY:
68666
show subpopulations
African (AFR)
AF:
0.726
AC:
3448
AN:
4750
American (AMR)
AF:
0.588
AC:
2237
AN:
3802
Ashkenazi Jewish (ASJ)
AF:
0.540
AC:
3475
AN:
6432
East Asian (EAS)
AF:
0.692
AC:
11687
AN:
16886
South Asian (SAS)
AF:
0.537
AC:
634
AN:
1180
European-Finnish (FIN)
AF:
0.424
AC:
3633
AN:
8576
Middle Eastern (MID)
AF:
0.596
AC:
434
AN:
728
European-Non Finnish (NFE)
AF:
0.490
AC:
42927
AN:
87592
Other (OTH)
AF:
0.541
AC:
5278
AN:
9754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1500
2999
4499
5998
7498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.583
AC:
88568
AN:
151870
Hom.:
26554
Cov.:
32
AF XY:
0.582
AC XY:
43187
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.735
AC:
30495
AN:
41468
American (AMR)
AF:
0.607
AC:
9276
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.548
AC:
1898
AN:
3466
East Asian (EAS)
AF:
0.725
AC:
3712
AN:
5120
South Asian (SAS)
AF:
0.551
AC:
2656
AN:
4816
European-Finnish (FIN)
AF:
0.448
AC:
4718
AN:
10530
Middle Eastern (MID)
AF:
0.565
AC:
165
AN:
292
European-Non Finnish (NFE)
AF:
0.502
AC:
34107
AN:
67876
Other (OTH)
AF:
0.613
AC:
1289
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1893
3786
5680
7573
9466
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
736
1472
2208
2944
3680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.358
Hom.:
831
Bravo
AF:
0.605
Asia WGS
AF:
0.606
AC:
2099
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
6.0
DANN
Benign
0.47
PhyloP100
-0.17
PromoterAI
0.011
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13207351; hg19: chr6-43737794; COSMIC: COSV57878443; API